FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

4 letters match. Newest first.

  1. Peter Michael, M.D.

    FDA warns clinical investigator Peter Michael, M.D. that pediatric trial subjects received twice the protocol's maximum drug dose.

    High risk
  2. Americo F. Padilla, M.D.

    FDA warns clinical investigator Americo F. Padilla, M.D. over failing to obtain parental consent before enrolling pediatric subjects in drug trials.

    High risk
  3. Robert J. Hayashi, M.D./Washington University School of Medicine, Department of Pediatrics

    FDA warned Dr. Robert J. Hayashi over protocol deviations in pediatric drug trials that exposed a child to unnecessary study drug and invasive procedures.

    High risk
  4. Evelyn Lopez-Brignoni, M.D.

    FDA warns Dr. Evelyn Lopez-Brignoni over inadequate dosing in pediatric investigational drug trials.

    High risk